Robert J. Terifay, SVP Commercial at REGENERON PHARMACEUTICALS INC (REGN), sold 16,923 shares at $260.86 ($4.4M) on 2013-05-08, disclosed to the SEC on 2013-05-09.
Open-market sale of $4.4M REGN by SVP Commercial. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $261.67 | 6,857 | $1.8M | 40.6% |
| 2 | $261.67 | 750 | $196K | 4.4% |
| 3 | $261.67 | 946 | $248K | 5.6% |
| 4 | $261.67 | 139 | $36K | 0.8% |
| 5 | $260.86 | 3,394 | $885K | 20.0% |
| 6 | $261.44 | 4,437 |
| $1.2M |
| 26.2% |
| 7 | $262.06 | 400 | $105K | 2.4% |
| Total | $261.46 avg | 16,923 | $4.4M | 100% |
| Filing → |
| REGN | SELL | 2015-03-18 | $5.0M | — | Filing → |
| REGN | SELL | 2015-02-25 | $4.7M | — | Filing → |
| REGN | SELL | 2014-11-19 | $9.1M | — | Filing → |